BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 26029987)

  • 1. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Cervigni M
    Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause.
    Gambacciani M; Levancini M
    Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
    Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
    Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence.
    Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M
    Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause.
    Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M
    Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors.
    Gambacciani M; Levancini M
    Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser therapy for the restoration of vaginal function.
    Gambacciani M; Palacios S
    Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM).
    Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY
    Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microablative fractional CO
    Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
    Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcutaneous Temperature Controlled Radiofrequency (TTCRF) for the Treatment of Menopausal Vaginal/Genitourinary Symptoms.
    Leibaschoff G; Izasa PG; Cardona JL; Miklos JR; Moore RD
    Surg Technol Int; 2016 Oct; 29():149-159. PubMed ID: 27608749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device.
    Vicariotto F; Raichi M
    Minerva Ginecol; 2016 Jun; 68(3):225-36. PubMed ID: 27206062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study.
    Gambacciani M; Albertin E; Torelli MG; Bracco GL; Casagrande AC; Martella L; Baiocchi G; Alfieri S; Russo N; Cervigni M;
    Climacteric; 2020; 23(sup1):S24-S27. PubMed ID: 33124454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design for fractional microablative CO
    Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
    Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study.
    Gambacciani M; Fidecicchi T
    Climacteric; 2022 Apr; 25(2):208-211. PubMed ID: 35006008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genitourinary syndrome of menopause (GSM) and laser VEL: a review.
    Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E
    Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic quadripolar radiofrequency treatment of vaginal laxity/menopausal vulvo-vaginal atrophy: 12-month efficacy and safety.
    Vicariotto F; DE Seta F; Faoro V; Raichi M
    Minerva Ginecol; 2017 Aug; 69(4):342-349. PubMed ID: 28608667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Fractional CO
    Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
    Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study.
    Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z
    Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors.
    Fidecicchi T; Gaspar A; Gambacciani M
    Menopause; 2023 Feb; 30(2):174-178. PubMed ID: 36696641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Two wavelengths endovaginal laser system": Clinical evaluation of a new device for mild SUI and vaginal atrophy treatment.
    Mezzana P
    Dermatol Ther; 2020 Nov; 33(6):e14445. PubMed ID: 33098352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.